Levofloxacin Tablet, Film Coated
Product Images NDC 68071-4512

6 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 68071-4512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4512 1

68071 4512 1
Label for Levofloxacin 500 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label includes dosage form as tablet, with each tablet containing 500 mg of Levofloxacin. Instructions note the tablet is capsule-shaped orange with debossed markings '26' and '1'. The label also features storage instructions, warnings, manufacturer information, and barcodes with NDC 68071-4512.*
FDA Label Image

Levofloxacinaddress1 (Levofloxacinaddress1)

FDA Label Image

Levofloxacinaddress2 (Levofloxacinaddress2)

FDA Label Image

Levofloxacinfigure1 (Levofloxacinfigure1)

Levofloxacinfigure1 (Levofloxacinfigure1)
Chemical structure of Levofloxacin, showing the molecular configuration including a fluorine-substituted aromatic ring, ketone, and other characteristic groups, alongside a notation indicating half a molecule of water (½ H2O).*
FDA Label Image

Levofloxacinfigure2 (Levofloxacinfigure2)

Levofloxacinfigure2 (Levofloxacinfigure2)
A line graph showing plasma concentration (µg/mL) over time (hours) for a 750 mg dose of Levofloxacin. It compares plasma concentration profiles after oral tablet administration and intravenous infusion (90-minute), with time points extending up to 36 hours.*
FDA Label Image

Levofloxacinfigure3 (Levofloxacinfigure3)

Levofloxacinfigure3 (Levofloxacinfigure3)
A line graph depicting the plasma concentration (mcg/mL) of 500 mg Levofloxacin over time (hours). It compares two administration routes: oral (p.o.) tablets and intravenous (i.v.) injection, showing plasma concentration decline over a 36-hour period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.